Your browser is no longer supported. Please, upgrade your browser.
EBS Emergent BioSolutions Inc. daily Stock Chart
EBS [NYSE]
Emergent BioSolutions Inc.
Index- P/E- EPS (ttm)-0.02 Insider Own3.00% Shs Outstand51.48M Perf Week2.10%
Market Cap3.32B Forward P/E18.41 EPS next Y3.51 Insider Trans-7.35% Shs Float43.39M Perf Month12.67%
Income-0.10M PEG- EPS next Q1.73 Inst Own91.50% Short Float5.92% Perf Quarter18.82%
Sales1.02B P/S3.27 EPS this Y-30.90% Inst Trans2.09% Short Ratio8.45 Perf Half Y50.54%
Book/sh20.06 P/B3.22 EPS next Y18.08% ROA0.20% Target Price68.67 Perf Year-0.87%
Cash/sh2.70 P/C23.88 EPS next 5Y9.20% ROE0.40% 52W Range39.11 - 67.45 Perf YTD19.70%
Dividend- P/FCF- EPS past 5Y6.00% ROI3.70% 52W High-1.02% Beta1.58
Dividend %- Quick Ratio1.70 Sales past 5Y20.10% Gross Margin60.40% 52W Low70.71% ATR1.76
Employees1705 Current Ratio2.50 Sales Q/Q79.50% Oper. Margin4.70% RSI (14)77.01 Volatility2.58% 2.90%
OptionableYes Debt/Eq0.80 EPS Q/Q104.00% Profit Margin0.40% Rel Volume3.78 Prev Close64.58
ShortableYes LT Debt/Eq0.79 EarningsFeb 20 AMC Payout0.00% Avg Volume303.76K Price66.76
Recom1.70 SMA2011.45% SMA5017.79% SMA20031.71% Volume700,448 Change3.38%
Sep-12-19Initiated Guggenheim Buy
Sep-04-19Upgrade Wells Fargo Market Perform → Outperform
Nov-02-18Upgrade Goldman Neutral → Buy
Aug-03-18Reiterated Chardan Capital Markets Buy $53 → $57
Jun-13-18Initiated Argus Buy $62
Apr-25-18Downgrade Wells Fargo Outperform → Market Perform
Jan-24-18Initiated Goldman Neutral
Jan-16-18Reiterated Chardan Capital Markets Buy $47 → $53
Jun-28-16Reiterated Singular Research Buy $44 → $40
Apr-15-16Initiated Chardan Capital Markets Buy $47
Mar-28-16Initiated Singular Research Buy $44
Feb-19-16Initiated Wells Fargo Outperform
May-15-14Initiated Summer Street Research Buy $35
May-31-11Reiterated WBB Securities Strong Buy $20.50 → $30
Jan-10-11Reiterated Wedbush Outperform $27 → $32
Nov-05-10Reiterated Wedbush Outperform $22 → $27
Aug-18-10Upgrade WBB Securities Buy → Strong Buy $20.50
Aug-06-10Reiterated Caris & Company Buy $25 → $23
Jul-14-10Upgrade WBB Securities Hold → Buy $15.60 → $20.50
May-06-10Downgrade WBB Securities Buy → Hold $15.60
Feb-21-20 02:33AM  Edited Transcript of EBS earnings conference call or presentation 20-Feb-20 10:00pm GMT Thomson Reuters StreetEvents
Feb-20-20 04:31PM  Emergent BioSolutions Reports Financial Results for Fourth Quarter and Full Year 2019 GlobeNewswire
Feb-06-20 10:44AM  Emmaus (EMMA) to Report Q4 Earnings: What's in the Cards? Zacks
Feb-03-20 04:30PM  Emergent BioSolutions to Release Fourth Quarter and Full Year 2019 Financial Results and Conduct a Conference Call on February 20, 2020 GlobeNewswire
Jan-31-20 09:26AM  Emergent BioSolutions Receives Positive CHMP Opinion for Vaxchora; Anticipates Near-Term Approval by European Medicines Agency GlobeNewswire
Jan-23-20 06:17AM  Does The Emergent BioSolutions Inc. (NYSE:EBS) Share Price Fall With The Market? Simply Wall St.
Jan-14-20 10:03AM  Emergent (EBS) Posts Preliminary '19 Results, Gives 2020 View Zacks
Jan-13-20 06:40AM  Emergent BioSolutions Receives EMA Agreement for Proposed Development Path of Investigational Chikungunya VLP Vaccine Candidate GlobeNewswire
06:30AM  Emergent BioSolutions Announces Preliminary 2019 Financial Results and Provides 2020 Financial Forecast GlobeNewswire
Jan-10-20 06:08PM  AMAG to Sell Women Healthcare Drugs, CEO Resigns, Stock Down Zacks
10:27AM  Blueprint Medicines' Ayvakit Gets FDA Nod for Rare Cancer Zacks
Jan-09-20 04:09PM  Catabasis (CATB) Partners with UK-Based Charity for DMD Study Zacks
10:31AM  Blueprint Medicines Posts Data From NSCLC Study on Pralsetinib Zacks
09:48AM  Agenus Initiates Phase I Study on Oncology Candidate AGEN1223 Zacks
09:00AM  The Zacks Analyst Blog Highlights: H&R Block, Berry Global Group, Emergent BioSolutions, Pilgrim's Pride and Alexion Pharmaceuticals Zacks
Jan-08-20 11:40AM  EBS vs. ILMN: Which Stock Is the Better Value Option? Zacks
11:26AM  Incyte's Application for Pemigatinib Gets EMA's Validation Zacks
08:30AM  5 Top Value Picks to Counter Recent Stock Market Softness Zacks
Jan-06-20 06:30AM  Emergent BioSolutions to Participate in Investor Conferences GlobeNewswire
Dec-24-19 06:15AM  Emergent BioSolutions Appears on a Healthy Trajectory TheStreet.com
Dec-20-19 01:00PM  Emergent BioSolutions Board Members Dr. Sue Bailey and Dr. Kathryn C. Zoon Named Most Influential Corporate Directors GlobeNewswire
Dec-10-19 11:13AM  Hedge Funds Have Never Been This Bullish On Emergent Biosolutions Inc (EBS) Insider Monkey
Dec-06-19 11:31AM  Emergent Biosolutions (EBS) Down 4.4% Since Last Earnings Report: Can It Rebound? Zacks
Nov-22-19 08:19AM  Emergent BioSolutions Presents Positive Immunogenicity Results From Phase 2 Study of Its Investigational Chikungunya VLP Vaccine Candidate GlobeNewswire
Nov-21-19 04:05PM  Emergent BioSolutions Announces Growth Strategy and 2024 Goals at Analyst and Investor Day GlobeNewswire
Nov-18-19 06:30AM  Emergent BioSolutions to Host 2019 Analyst and Investor Day GlobeNewswire
Nov-13-19 02:48PM  Edited Transcript of EBS earnings conference call or presentation 6-Nov-19 10:00pm GMT Thomson Reuters StreetEvents
09:30AM  EBS or ILMN: Which Is the Better Value Stock Right Now? Zacks
Nov-07-19 11:20AM  Emergent (EBS) Beat Earnings in Q3, Vaccines Drive Sales Zacks -5.82%
Nov-06-19 07:05PM  Emergent Biosolutions (EBS) Q3 Earnings and Revenues Beat Estimates Zacks
04:05PM  Emergent BioSolutions Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2019 GlobeNewswire
Oct-30-19 10:34AM  Emergent Biosolutions (EBS) Earnings Expected to Grow: Should You Buy? Zacks
Oct-25-19 09:33AM  Can You Imagine How Chuffed Emergent BioSolutions's (NYSE:EBS) Shareholders Feel About Its 142% Share Price Gain? Simply Wall St.
Oct-21-19 11:34AM  Heres What Hedge Funds Think About Emergent Biosolutions Inc (EBS) Insider Monkey -5.17%
06:30AM  Emergent BioSolutions to Host 2019 Analyst & Investor Day GlobeNewswire
Oct-11-19 12:53PM  Emergent's Chikungunya Vaccine Candidate Gets EMA's PRIME Tag Zacks
Oct-10-19 09:34AM  New Stocks on the Argus Focus List Yahoo Finance
06:38AM  Emergent BioSolutions Receives EMA Prime Designation for Its Chikungunya Virus VLP Vaccine Candidate GlobeNewswire
Oct-09-19 06:30AM  Emergent BioSolutions to Release Third Quarter 2019 Financial Results and Conduct a Conference Call on November 6, 2019 GlobeNewswire
Oct-08-19 10:31AM  Emergent's Vaccine Profile Boosts Sales Despite Stiff Rivalry Zacks
Sep-27-19 06:35AM  Emergent BioSolutions Receives NIH Research Grant to Further Develop AP007, Its Development Stage Sustained-Release Nalmefene Treatment for Opioid Use Disorder GlobeNewswire
Sep-26-19 02:46PM  Emergent lands $20M contract to develop chemical weapon antidote American City Business Journals
09:27AM  Emergent BioSolutions to Participate in Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-25-19 04:15PM  Emergent BioSolutions Awarded $20 Million to Develop Diazepam Auto-Injector to Treat Nerve Agent-Induced Seizures for U.S. Department of Defense GlobeNewswire
Sep-19-19 11:25AM  Emergent BioSolutions Inc. (NYSE:EBS) Insiders Have Been Selling Simply Wall St.
Sep-04-19 12:25PM  Wells Fargo Upgrades Emergent Biosolutions After Smallpox Vaccine Announcement Benzinga +11.69%
10:02AM  Company News For Sep 4, 2019 Zacks
Sep-03-19 01:28PM  Emergent lands federal contract for smallpox vaccine potentially worth more than $2B American City Business Journals +14.47%
12:55PM  Here's How Emergent BioSolutions Procured a Higher Price Today Motley Fool
06:30AM  Emergent BioSolutions Awarded 10-Year HHS Contract to Deliver ACAM2000®, (Smallpox (Vaccinia) Vaccine, Live) Into the Strategic National Stockpile GlobeNewswire
Aug-31-19 09:31AM  Emergent Biosolutions (EBS) Down 0.9% Since Last Earnings Report: Can It Rebound? Zacks
Aug-28-19 02:28PM  Emergent's Vaccine Portfolio Aids Growth Amid Competition Zacks
Aug-14-19 04:15PM  Emergent BioSolutions to Participate in Series of Investor Conferences GlobeNewswire
07:48AM  Here's Why Emergent BioSolutions (NYSE:EBS) Has A Meaningful Debt Burden Simply Wall St.
Aug-06-19 10:14AM  Emergent BioSolutions Looks to the Second Half for Growth Motley Fool
06:26AM  Emergent BioSolutions Inc (EBS) Q2 2019 Earnings Call Transcript Motley Fool
Aug-05-19 01:14PM  Edited Transcript of EBS earnings conference call or presentation 1-Aug-19 9:00pm GMT Thomson Reuters StreetEvents
Aug-02-19 10:52AM  Emergent (EBS) Earnings Miss in Q2, Revenues Beat Estimates Zacks
Aug-01-19 08:25PM  Emergent Biosolutions (EBS) Q2 Earnings Lag Estimates Zacks
04:05PM  Emergent BioSolutions Reports Financial Results for Second Quarter and Six Months Ended June 30, 2019 GlobeNewswire
Jul-30-19 04:42PM  Emergent BioSolutions Announces Exercise by BARDA of the First Contract Option, Valued at $261 Million, to Procure Doses of AV7909 Anthrax Vaccine Candidate for the Strategic National Stockpile GlobeNewswire
Jul-25-19 10:33AM  Earnings Preview: Emergent Biosolutions (EBS) Q2 Earnings Expected to Decline Zacks
Jul-18-19 06:30AM  Emergent BioSolutions to Release Second Quarter 2019 Financial Results and Conduct a Conference Call on August 1, 2019 GlobeNewswire
Jul-09-19 06:08AM  Here's What Emergent BioSolutions Inc.'s (NYSE:EBS) P/E Is Telling Us Simply Wall St.
Jun-28-19 06:12PM  Heres What Hedge Funds Think About Emergent Biosolutions Inc (EBS) Insider Monkey
Jun-14-19 02:27PM  Before You Buy Emergent BioSolutions Inc. (NYSE:EBS), Consider Its Volatility Simply Wall St.
Jun-05-19 01:20PM  Emergent BioSolutions CEO on fighting drug pricing and the opioid epidemic Yahoo Finance Video
09:52AM  Emergent BioSolutions Looks Like It Will Get a Shot in the Arm TheStreet.com
Jun-04-19 06:58PM  Don't Get Complacent: Cramer's 'Mad Money' Recap (Tuesday 6/4/19) TheStreet.com +5.02%
04:05PM  Emergent BioSolutions Announces FDA Approval of Change in Storage Conditions and Transfer of Manufacturing for Its Cholera Vaccine GlobeNewswire
11:52AM  Emergent (EBS) Wins HHS Contract to Supply VIGIV Product Zacks
Jun-03-19 02:53PM  What Emergents latest $535M contract means for national smallpox franchise American City Business Journals +8.24%
06:30AM  Emergent BioSolutions Awarded 10-Year HHS Contract Valued at Approximately $535 Million to Deliver Vaccinia Immune Globulin Intravenous (VIGIV) in Support of Smallpox Preparedness GlobeNewswire
Jun-01-19 09:31AM  Why Is Emergent Biosolutions (EBS) Down 23.4% Since Last Earnings Report? Zacks
May-23-19 07:15AM  You Might Like Emergent BioSolutions Inc. (NYSE:EBS) But Do You Like Its Debt? Simply Wall St.
May-20-19 04:05PM  Emergent BioSolutions Announces Granting of Marketing Authorization in Five EU Countries for Its Oral Typhoid Vaccine; Expands Availability Across Europe GlobeNewswire
06:30AM  Emergent BioSolutions to Participate in Series of Investor Conferences GlobeNewswire
May-15-19 04:05PM  Emergent BioSolutions Prepares for Initial Shipments of AV7909 Anthrax Vaccine Candidate into the Strategic National Stockpile GlobeNewswire
08:15AM  3 Top Healthcare Stocks to Buy in May Motley Fool
May-09-19 06:30AM  Emergent BioSolutions to Hold Annual Meeting of Stockholders on Thursday, May 23, 2019 at 9:00 AM EDT; Webcast Will Be Available GlobeNewswire
May-08-19 04:54PM  Emergent BioSolutions Negotiates for a Strong Second Half Motley Fool
May-07-19 09:42PM  Edited Transcript of EBS earnings conference call or presentation 2-May-19 9:00pm GMT Thomson Reuters StreetEvents
06:00AM  3 Top Biotech Stocks to Buy in May Motley Fool
May-03-19 03:41PM  Emergent (EBS) Earnings & Revenues Miss Estimates in Q1 Zacks -9.89%
03:07PM  Why Emergent BioSolutions Stock Is Tanking Today Motley Fool
08:14AM  Emergent BioSolutions Inc (EBS) Q1 2019 Earnings Call Transcript Motley Fool
07:38AM  New Strong Sell Stocks for May 3rd Zacks
May-02-19 07:25PM  Emergent Biosolutions (EBS) Reports Q1 Loss, Misses Revenue Estimates Zacks
06:18PM  Emergent Biosolutions: 1Q Earnings Snapshot Associated Press
04:05PM  Emergent BioSolutions Reports First Quarter 2019 Financial Results GlobeNewswire
Apr-30-19 08:52AM  What Are Analysts Saying About Emergent BioSolutions Inc.'s (NYSE:EBS) Earnings Trajectory? Simply Wall St.
Apr-26-19 11:51AM  Is Emergent Biosolutions Inc (EBS) A Good Stock To Buy ? Insider Monkey
Apr-25-19 10:34AM  Emergent Biosolutions (EBS) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Apr-19-19 12:04PM  FDA approves first generic naloxone nasal spray to treat opioid overdose MarketWatch
Apr-18-19 07:22AM  Emergent BioSolutions to Release First Quarter 2019 Financial Results and Conduct a Conference Call on May 2, 2019 GlobeNewswire
Apr-17-19 11:01AM  Emergent's (EBS) Chikungunya Vaccine Positive in Phase II Study Zacks
Apr-16-19 06:30AM  Emergent BioSolutions Announces Interim Results From Phase 2 Study Evaluating CHIKV-VLP, Chikungunya Virus Vaccine Candidate GlobeNewswire
Apr-10-19 10:08AM  What Should We Expect From Emergent BioSolutions Inc.'s (NYSE:EBS) Earnings In The Year Ahead? Simply Wall St.
Apr-09-19 10:59AM  Emergent's (EBS) Strong Vaccine Portfolio to Fuel Growth Zacks
Mar-23-19 09:30AM  Emergent Biosolutions (EBS) Down 24.2% Since Last Earnings Report: Can It Rebound? Zacks
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of specialty products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats (PHTs). Its products address PHTs, including chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travelers' diseases; and opioids. The company offers BioThrax, an anthrax vaccine; ACAM2000, a smallpox vaccine; Vaxchora, a cholera vaccine; and Vivotif, a typhoid vaccine. It also provides NARCAN for the emergency treatment of known or suspected opioid overdose; RSDL (Reactive Skin Decontamination Lotion Kit), a medical device to remove or neutralize chemical warfare agents from the skin; and Trobigard for intramuscular self-injection of atropine sulfate and obidoxime chloride. In addition, the company offers raxibacumab for the treatment and prophylaxis of inhalational anthrax; Anthrasil to treat inhalational anthrax; BAT (Botulism Antitoxin Heptavalent) for treating botulinum disease; and VIGIV (vaccinia immune globulin intravenous) that addresses complications from smallpox vaccination. Further, it provides NuThrax, an anthrax vaccine; CHIKUNGUNYA, a chikungunya virus-like particle vaccine; ADENOVIRUS 4/7, a live attenuated vaccine; rVSV-Lassa, a vaccine for prevention of Lassa fever; rVSV-Marburg, a vaccine for prevention of Marburg hemorrhagic fever; rVSV-Sudan, vaccine for prevention of Sudan hemorrhagic fever; rVSV-QUAD, a vaccine for prevention of hemorrhagic fever; and rVSV-Ebola, a vaccine for prevention of Ebola hemorrhagic fever. Additionally, the company offers FLU-IGIV to treat Influenza A infection in hospitalized patients; and ZIKV-IG, a prophylaxis for Zika infections, as well as contract manufacturing services to third-party customers. Emergent BioSolutions Inc. was founded in 1998 and is headquartered in Gaithersburg, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
El-Hibri FuadChairmanFeb 18Option Exercise25.6215,614400,0311,494,632Feb 19 09:00 PM
El-Hibri FuadChairmanFeb 18Sale63.9015,614997,7351,479,018Feb 19 09:00 PM
El-Hibri FuadChairmanFeb 14Option Exercise25.624,386112,3691,483,404Feb 19 09:00 PM
El-Hibri FuadChairmanFeb 14Sale63.904,386280,2651,479,018Feb 19 09:00 PM
El-Hibri FuadChairmanFeb 12Option Exercise25.6213,720351,5061,492,738Feb 13 06:30 PM
El-Hibri FuadChairmanFeb 12Sale62.9013,720862,9881,479,018Feb 13 06:30 PM
El-Hibri FuadChairmanFeb 11Option Exercise25.626,280160,8941,485,298Feb 13 06:30 PM
El-Hibri FuadChairmanFeb 11Sale62.906,280395,0121,479,018Feb 13 06:30 PM
El-Hibri FuadExecutive ChairmanFeb 06Sale61.9011,684723,2401,419,018Feb 07 06:31 PM
El-Hibri FuadExecutive ChairmanFeb 05Sale60.6648,3162,930,8491,430,702Feb 07 06:31 PM
Harsanyi ZsoltDirectorJan 16Sale55.003,435188,92536,273Jan 17 04:19 PM
Bailey SueDirectorDec 12Sale53.468,375447,72846,333Dec 13 09:21 AM
Zoon Kathryn CDirectorNov 18Sale54.311,00054,31417,412Nov 19 04:11 PM
Zoon Kathryn CDirectorNov 08Sale54.153,082166,88418,412Nov 12 09:52 AM
Richard RonaldDirectorNov 07Option Exercise18.645,15396,05231,852Nov 12 09:51 AM
Richard RonaldDirectorNov 07Sale60.005,153309,18026,699Nov 12 09:51 AM
Zoon Kathryn CDirectorSep 09Sale56.121,50984,69221,494Sep 10 05:44 PM
Zoon Kathryn CDirectorMay 28Sale43.391,37659,70223,003May 28 08:18 PM
SULLIVAN LOUIS WDirectorMay 07Option Exercise13.377,893105,52956,865May 09 05:18 PM
Havey AdamEVP, Business OperationsMar 11Sale56.932,430138,34032,240Mar 13 05:10 PM
Abdun-Nabi DanielCEOMar 04Sale58.1114,565846,328142,617Mar 04 06:39 PM
Havey AdamEVP, Business OperationsMar 01Sale58.202,024117,79734,670Mar 04 06:40 PM
Havey AdamEVP, Business OperationsFeb 28Sale57.921,01959,02236,694Mar 04 06:40 PM
El-Hibri FuadChairmanFeb 28Sale58.476,987408,5301,473,122Feb 28 07:21 PM
El-Hibri FuadChairmanFeb 27Sale58.2410,369603,8911,472,801Feb 28 07:21 PM
El-Hibri FuadChairmanFeb 26Sale59.6510,369618,5111,478,306Feb 28 07:21 PM